Vinflunine: A new anti-cancer fluorinated agent derived from Vinca-alkaloïds;La vinflunine, nouvel agent anticancéreux fluoré dérivé des alcaloïdes de Vinca

Annales Pharmaceutiques Francaises

Volumn 63, Issue 1, 2005, Pages 28-34

  Jacquesy, J C ^b   Jouannetaud, M P ^a  

^a UMR 6514 Synt/Reactiv Subs Nat   (France)

^b NONE

Author keywords

Antitumor activity; Superacid; Vinca alkaloids; Vinflunine

Indexed keywords

NAVELBINE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINFLUNINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CLINICAL TRIAL; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; ION EXCHANGE; ISOMERIZATION; LUNG NON SMALL CELL CANCER; REACTION ANALYSIS; REDUCTION;

EID: 14344249991     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4509(05)82248-5     Document Type: Article

References (35)

1. Blasko G, Cordell GA, Antitumor Bisindole Alkaloids from Catharanthus roseus (L.). The Alkaloids, Brossi A, Suffness M, San Diego, Academic Press 1990; 37: 1-76.
2. Noble RL. The discovery of the Vinca alkaloids. Chemotherapeutic agents against cancer. Biochem Cell Biol 1990; 68: 1344-51.
3. Mangeney P, Andriamialisoa RZ, Langlois N, Langlois Y, Potier P. Preparation of vinblastine, vincristine and leurosidine, antitumor alkaloids from catharanthus spp.(apocynaceae). J Am Chem Soc 1979; 101: 2243-5.
4. Kuehne ME, Zebovitz TC, Bornmann WG, Marko I. Three routes to the critical C16′-C14′ part relative stereochemistry of vinblastine. Syntheses of 20′-desethyl-20′-deoxyvinblastine and 20′-desethyl-20′deoxyvincovaline. J Org Chem 1987; 52: 4340-9; Kuehne ME, Bornmann WG. Syntheses of 20′-desoxyvinblastine, 20′-deoxyleurosidine, 20′-deoxyvincovaline, 20′-epi-20′- deoxyvincovaline and 20′-deoxyvincristine and its 20′-epimer through racemic and enantioselective generated intermediates. New syntheses of D/E-cis-and-trans-ψ-vincadifformine and D/E-cis-and-trans-20-epi- ψvincadifformine. J Org Chem 1989; 54: 3407-20; Kuehne ME, Matson PA, Bornmann WG. Enantioselective synthesis of vinblastine, leurosidine, vincovaline and 20′-epi-vincovaline. J Org Chem 1991; 56: 513-28.
5. Kuehne ME, Zebovitz TC, Bornmann WG, Marko I. Three routes to the critical C16′-C14′ part relative stereochemistry of vinblastine. Syntheses of 20′-desethyl-20′-deoxyvinblastine and 20′-desethyl-20′deoxyvincovaline. J Org Chem 1987; 52: 4340-9; Kuehne ME, Bornmann WG. Syntheses of 20′-desoxyvinblastine, 20′-deoxyleurosidine, 20′-deoxyvincovaline, 20′-epi-20′- deoxyvincovaline and 20′-deoxyvincristine and its 20′-epimer through racemic and enantioselective generated intermediates. New syntheses of D/E-cis-and-trans-ψ-vincadifformine and D/E-cis-and-trans-20-epi- ψvincadifformine. J Org Chem 1989; 54: 3407-20; Kuehne ME, Matson PA, Bornmann WG. Enantioselective synthesis of vinblastine, leurosidine, vincovaline and 20′-epi-vincovaline. J Org Chem 1991; 56: 513-28.
6. Kuehne ME, Zebovitz TC, Bornmann WG, Marko I. Three routes to the critical C16′-C14′ part relative stereochemistry of vinblastine. Syntheses of 20′-desethyl-20′-deoxyvinblastine and 20′-desethyl-20′deoxyvincovaline. J Org Chem 1987; 52: 4340-9; Kuehne ME, Bornmann WG. Syntheses of 20′-desoxyvinblastine, 20′-deoxyleurosidine, 20′-deoxyvincovaline, 20′-epi-20′- deoxyvincovaline and 20′-deoxyvincristine and its 20′-epimer through racemic and enantioselective generated intermediates. New syntheses of D/E-cis-and-trans-ψ-vincadifformine and D/E-cis-and-trans-20-epi- ψvincadifformine. J Org Chem 1989; 54: 3407-20; Kuehne ME, Matson PA, Bornmann WG. Enantioselective synthesis of vinblastine, leurosidine, vincovaline and 20′-epi-vincovaline. J Org Chem 1991; 56: 513-28.
7. Magnus P, Ladlow M, Elliot J. Models for a hypothetical mechanism of action of the anticancer agent vinblastine. J Am Chem Soc 1987; 109: 7929-30; Magnus P, Stamford A, Ladlow M. Synthesis of the antitumor bisindole alkaloid vinblastine. Diastereoselectivity and solvent effect on the stereochemistry of the crucial C15-C18′ bond. J Am Chem Soc 1990; 112: 8210-2; Magnus P, Ladlow M, Elliot J, Kim CS. Stereospecific synthesis of the top-half precursor to the antitumor agent vinblastine and a simple bisindole analogue. J Chem Soc, Chem Commun. 1989; 518-20. Magnus P, Mendoza J Tetrahedron Lett. 1992; 33: 899-902.
8. Magnus P, Ladlow M, Elliot J. Models for a hypothetical mechanism of action of the anticancer agent vinblastine. J Am Chem Soc 1987; 109: 7929-30; Magnus P, Stamford A, Ladlow M. Synthesis of the antitumor bisindole alkaloid vinblastine. Diastereoselectivity and solvent effect on the stereochemistry of the crucial C15-C18′ bond. J Am Chem Soc 1990; 112: 8210-2; Magnus P, Ladlow M, Elliot J, Kim CS. Stereospecific synthesis of the top-half precursor to the antitumor agent vinblastine and a simple bisindole analogue. J Chem Soc, Chem Commun. 1989; 518-20. Magnus P, Mendoza J Tetrahedron Lett. 1992; 33: 899-902.
9. Magnus P, Ladlow M, Elliot J. Models for a hypothetical mechanism of action of the anticancer agent vinblastine. J Am Chem Soc 1987; 109: 7929-30; Magnus P, Stamford A, Ladlow M. Synthesis of the antitumor bisindole alkaloid vinblastine. Diastereoselectivity and solvent effect on the stereochemistry of the crucial C15-C18′ bond. J Am Chem Soc 1990; 112: 8210-2; Magnus P, Ladlow M, Elliot J, Kim CS. Stereospecific synthesis of the top-half precursor to the antitumor agent vinblastine and a simple bisindole analogue. J Chem Soc, Chem Commun. 1989; 518-20. Magnus P, Mendoza J Tetrahedron Lett. 1992; 33: 899-902.
10. Magnus P, Ladlow M, Elliot J. Models for a hypothetical mechanism of action of the anticancer agent vinblastine. J Am Chem Soc 1987; 109: 7929-30; Magnus P, Stamford A, Ladlow M. Synthesis of the antitumor bisindole alkaloid vinblastine. Diastereoselectivity and solvent effect on the stereochemistry of the crucial C15-C18′ bond. J Am Chem Soc 1990; 112: 8210-2; Magnus P, Ladlow M, Elliot J, Kim CS. Stereospecific synthesis of the top-half precursor to the antitumor agent vinblastine and a simple bisindole analogue. J Chem Soc, Chem Commun. 1989; 518-20. Magnus P, Mendoza J Tetrahedron Lett. 1992; 33: 899-902.
11. Potier P, Langlois N, Langlois Y, Gueritte F. Partial synthesis of vinblastine-type alkaloids. J Chem Soc, Chem Commun 1975; 670-1; Langlois N, Potier P, Gueritte F, Langlois Y. Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids. J Am Chem Soc 1976; 98: 7017-24.
12. Potier P, Langlois N, Langlois Y, Gueritte F. Partial synthesis of vinblastine-type alkaloids. J Chem Soc, Chem Commun 1975; 670-1; Langlois N, Potier P, Gueritte F, Langlois Y. Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids. J Am Chem Soc 1976; 98: 7017-24.
13. Jacquesy JC, Fahy J. Cancer: Superacid generation of new antitumor agents Torrence PF, New York, John Wiley and Sons, 2000, Ch 10, 227-46.
14. Mangeney P, Andriamialisoa RZ, Lallemand JY, Langlois N, Langlois Y, Potier P. 5′-Noranhydrovinblastine. Prototype of a new class of vinblastine derivatives. Tetrahedron 1979; 35: 2175-9.
15. Hall NF, Conant JB. A study of superacid solutions. I The use of the chloranil electrode in glacial acetic acid and the strength of certain weak bases. J Am Chem Soc 1927; 49: 3047-61.
16. Olah GA, Surya Prakash GK, Sommer J. Superacids, New York, John Wiley and Sons, 1985.
17. Gillespie RJ, Peel TE. Superacid system Adv Phys Org Chem 1971; 9: 1-24; Gillespie RJ, Peel TE. Hammett acidity function for some superacid system. II Systems sulfuric acid- [fsa], potassium fluorosulfate-fsa, [fsa]-sulfur trioxide, - [fsa]-arsenic pentafluoride, - [fsa]-antimony pentafluoride and - [fsa]antimony penta-fluoride-sulfur trioxide. J Am Chem Soc 1973; 95: 5173-9.
18. Gillespie RJ, Peel TE. Superacid system Adv Phys Org Chem 1971; 9: 1-24; Gillespie RJ, Peel TE. Hammett acidity function for some superacid system. II Systems sulfuric acid- [fsa], potassium fluorosulfate-fsa, [fsa]-sulfur trioxide, - [fsa]-arsenic pentafluoride, - [fsa]-antimony pentafluoride and - [fsa]antimony penta-fluoride-sulfur trioxide. J Am Chem Soc 1973; 95: 5173-9.
19. Jacquesy JC. Natural product chemistry in superacids in Stable carbocation chemistry, Surya Prakash GK, v.R.Schleyer P., New York, John Wiley and Sons, 1997, Ch 17, 549-74.
20. Berrier C, Jacquesy JC, Jouannetaud MP, Lafitte C, Vidal Y, Zunino F et al. Functionalization of non activated C-H bond: Fluorination of vindoline at C20 in superacids. Tetrahedron 1998; 54: 13761-70.
21. Fahy J, Duflos A, Ribet JP, Jacquesy JC, Berrier C, Jouannetaud MP et al. Vinca alkaloids in superacidic media: a method for creating a new family antitumor derivatives. J Am Chem Soc 1997; 119: 8576-7.
22. Jacquesy JC, Fahy J, Berrier C, Bigg D, Jouannetaud MP, Zunino F et al. (Pierre Fabre Médicament). Novel antimitotic binary alkaloid derivatives extracted from Catharanthus roseus. EP 0710240, FR 2707988, US 5620985, WO 9503312.
23. 4 or NBS in superacids. Tetrahedron Lett 1996; 37: 2967-70.
24. 4 or NBS in superacids. Tetrahedron Lett 1996; 37: 2967-70.
25. 4 or NBS in superacids. Tetrahedron Lett 1996; 37: 2967-70.
26. Lafitte C, Jouannetaud MP, Jacquesy JC, Fahy J, Duflos A. Stereoselective ionic hydrogenation of Vinca alkaloids and vinorelbine in superacids: an access to 4′R-reduced analogs. Tetrahedron Lett 1998; 39: 8281-2.
27. Gaskin F, Cantor CR, Shelanski ML. Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules. J Molec Biol 1974; 89: 737-58.
28. Duflos A, Kruczynski A, Barret JM. Novels aspects of natural and modified Vinca alcaloids. Curr Med Chem - Anti-Cancer agents 2002; 2: 55-70.
29. Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Biochem Pharmacol 1998; 55: 635-48.
30. Decoster J, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT. Vinflunine, a new Vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasique and mitotic microtubule cytoskeleton of PtK2 cells. Anti cancer drugs 1999; 10: 537-43.
31. Kruczynski A, Hill BT. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit Rev Oncol Hematol 2001; 40: 159-73.
32. Kruczynski A, Colpaert F, Tarayre JP, Mouillard P, Fahy J, Hill BT. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Cancer Chemother Pharmacol 1998; 41: 437-47.
33. Fahy J, Duflos A, Schambel P, Kruczynski A, Etievant C, Barret JM et al. Vinflunine and derivatives: a novel class of antitumour Vinca alkaloids. Proc Am Assoc Cancer Res 1998; 39: 1136.
34. Barret JM, Etiévant C, Hill BT. In vitro synergistic effects of vinflunine, a novel fluorinated Vinca alkaloid, in combinaison with other anticancer drugs. Cancer Chemother. Pharmacol 2000; 45: 471-476; Vinflunine drugs of the future 2004; 29: 574-80.
35. Barret JM, Etiévant C, Hill BT. In vitro synergistic effects of vinflunine, a novel fluorinated Vinca alkaloid, in combinaison with other anticancer drugs. Cancer Chemother. Pharmacol 2000; 45: 471-476; Vinflunine drugs of the future 2004; 29: 574-80.